[Current status and future perspectives of living kidney transplantation from ABO-incompatible or spousal donors].
Tanabe
Kazunari
K
Department of Urology, Graduate School of Medicine, Tokyo Women's Medical School, Tokyo, Japan.
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D058846:Antibodies, Monoclonal, Murine-Derived; D001787:Blood Group Incompatibility; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control*; D006085:Graft Survival; D006801:Humans; D007155:Immunologic Factors / Q000627:therapeutic use; D007165:Immunosuppression Therapy / Q000379:methods / Q000639:trends*; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007398:Interpersonal Relations; D016030:Kidney Transplantation / Q000523:psychology / Q000639:trends*; D019520:Living Donors; D008297:Male; D010951:Plasma Exchange; D000069283:Rituximab; D013156:Splenectomy; D018454:Spouses / Q000523:psychology
D000017:ABO Blood-Group System; D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D007155:Immunologic Factors; D007166:Immunosuppressive Agents; D000069283:Rituximab